Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-08-23
2011-08-23
Kosack, Joseph (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S235500, C546S017000, C540S543000, C544S070000
Reexamination Certificate
active
08003660
ABSTRACT:
The present invention relates to benzo-spiro-azaheterocyclic compounds of formula I, wherein R1, R2a, Rsb, R3, R′3, R4, R′4, m, n, q and p are define herein. The compounds of this invention are useful as modulators of muscarinic receptors. The present invention also provides compositions comprising such modulators, and methods therewith for treating muscarinic receptor mediated diseases
REFERENCES:
patent: 3654287 (1972-04-01), Dykstra
patent: 3666764 (1972-05-01), Campbell et al.
patent: 3959475 (1976-05-01), Bauer et al.
patent: 3962259 (1976-06-01), Bauer et al.
patent: 4233307 (1980-11-01), Ono et al.
patent: 4349549 (1982-09-01), Roszkowski et al.
patent: 4558049 (1985-12-01), Bernardi et al.
patent: 5091387 (1992-02-01), Evans et al.
patent: 5219860 (1993-06-01), Chambers et al.
patent: 5324733 (1994-06-01), Billington et al.
patent: 5457207 (1995-10-01), Efange et al.
patent: 5576321 (1996-11-01), Krushinski, Jr. et al.
patent: 5578593 (1996-11-01), Chen et al.
patent: 5614523 (1997-03-01), Audia et al.
patent: 5627196 (1997-05-01), Audia et al.
patent: 5652235 (1997-07-01), Chen et al.
patent: 5658921 (1997-08-01), Perregaard et al.
patent: 5693643 (1997-12-01), Gilbert et al.
patent: 5741789 (1998-04-01), Hibschman et al.
patent: 5789402 (1998-08-01), Audia et al.
patent: 5817679 (1998-10-01), Shen et al.
patent: 5885999 (1999-03-01), Elliott et al.
patent: 6013652 (2000-01-01), Maccoss et al.
patent: 6130217 (2000-10-01), Arnold et al.
patent: 6166037 (2000-12-01), Budhu et al.
patent: 6166040 (2000-12-01), Fairhurst et al.
patent: 6294534 (2001-09-01), Nargund et al.
patent: 6316437 (2001-11-01), Hoffman
patent: 6326375 (2001-12-01), Fukami et al.
patent: 6413961 (2002-07-01), Demopulos et al.
patent: 6436962 (2002-08-01), Hoffman et al.
patent: 6566367 (2003-05-01), Bakthavatchalam et al.
patent: 6576664 (2003-06-01), Yao et al.
patent: 6713487 (2004-03-01), Yu et al.
patent: 6720324 (2004-04-01), Marzabadi et al.
patent: 6828440 (2004-12-01), Goehring et al.
patent: 6869960 (2005-03-01), Ito et al.
patent: 6943199 (2005-09-01), De Lombaert et al.
patent: 7045527 (2006-05-01), Chen et al.
patent: 7205417 (2007-04-01), Fukami et al.
patent: 7279471 (2007-10-01), Mueller et al.
patent: 7351706 (2008-04-01), Bissantz et al.
patent: 7491715 (2009-02-01), Ek et al.
patent: 2002/0188124 (2002-12-01), Fukami et al.
patent: 2003/0036652 (2003-02-01), Bakthavatchalam et al.
patent: 2003/0082623 (2003-05-01), Borowsky et al.
patent: 2003/0158219 (2003-08-01), Ito et al.
patent: 2004/0038855 (2004-02-01), Salon et al.
patent: 2004/0050285 (2004-03-01), Zozulya et al.
patent: 2004/0054177 (2004-03-01), Otake et al.
patent: 2004/0072847 (2004-04-01), Bakthavatchalam et al.
patent: 2004/0082623 (2004-04-01), Rochhi et al.
patent: 2004/0122074 (2004-06-01), Dow et al.
patent: 2004/0142956 (2004-07-01), Chen et al.
patent: 2004/0204397 (2004-10-01), Chaturvedula et al.
patent: 2004/0214837 (2004-10-01), Griffith et al.
patent: 2005/0033048 (2005-02-01), Bakthavatchalam et al.
patent: 2005/0143372 (2005-06-01), Ghosh et al.
patent: 2005/0153998 (2005-07-01), Ito et al.
patent: 2005/0176703 (2005-08-01), Gabriel et al.
patent: 2005/0215576 (2005-09-01), Degnan et al.
patent: 2005/0261332 (2005-11-01), Distefano et al.
patent: 2006/0019962 (2006-01-01), Makings et al.
patent: 2006/0040964 (2006-02-01), Bakthavatchalam et al.
patent: 2006/0058778 (2006-03-01), Arcusa Villacampa et al.
patent: 2006/0106045 (2006-05-01), Hughes et al.
patent: 2006/0111380 (2006-05-01), Otake et al.
patent: 2006/0173027 (2006-08-01), Marzabadi et al.
patent: 2006/0183904 (2006-08-01), Guo et al.
patent: 2006/0211722 (2006-09-01), Jiao et al.
patent: 2006/0217372 (2006-09-01), Blanco-Pillado et al.
patent: 2006/0270673 (2006-11-01), Duggan et al.
patent: 2007/0043023 (2007-02-01), Makings et al.
patent: 2007/0149502 (2007-06-01), Chaturvedula et al.
patent: 2007/0213315 (2007-09-01), Davies
patent: 2007/0254903 (2007-11-01), Boatman et al.
patent: 2008/0033002 (2008-02-01), Bandarage et al.
patent: 2008/0171753 (2008-07-01), Jitsuoka et al.
patent: 1535967 (2004-10-01), None
patent: 3433327 (1985-03-01), None
patent: 0070171 (1983-01-01), None
patent: 0128886 (1984-12-01), None
patent: 0414289 (1991-02-01), None
patent: 0444945 (1991-09-01), None
patent: 0445974 (1991-09-01), None
patent: 0486280 (1992-05-01), None
patent: 0518805 (1992-12-01), None
patent: 0722941 (1996-07-01), None
patent: 1575800 (1980-10-01), None
patent: 2308064 (1997-06-01), None
patent: 2001/278886 (2001-10-01), None
patent: 2002/316987 (2002-10-01), None
patent: WO 94/22846 (1994-10-01), None
patent: WO 95/11029 (1995-04-01), None
patent: WO 95/14025 (1995-05-01), None
patent: WO 95/28389 (1995-10-01), None
patent: WO 97/41878 (1997-11-01), None
patent: WO 97/41879 (1997-11-01), None
patent: WO 99/06434 (1999-02-01), None
patent: WO 99/32489 (1999-07-01), None
patent: WO 00/06146 (2000-02-01), None
patent: WO 00/06153 (2000-02-01), None
patent: WO 00/06545 (2000-02-01), None
patent: WO 00/38720 (2000-07-01), None
patent: WO 01/02386 (2001-01-01), None
patent: WO 01/22919 (2001-04-01), None
patent: WO 01/45707 (2001-06-01), None
patent: WO 01/64213 (2001-09-01), None
patent: WO 02/094825 (2002-11-01), None
patent: WO 03/095427 (2003-11-01), None
patent: WO 2004/010942 (2004-02-01), None
patent: WO 2004/010943 (2004-02-01), None
patent: WO 2004/011427 (2004-02-01), None
patent: WO 2005/065779 (2005-07-01), None
patent: WO 2005111003 (2005-11-01), None
patent: WO 2006/001958 (2006-01-01), None
patent: WO 01/29027 (2007-04-01), None
Patrick, G. L. J. Chem. Soc. Perkin Trans I, 1995, 10, 1273-1279.
Berney et al. Helvetica Chimica Acta 1974, 57, 1198-1204.
CAS Registry entry for Registry No. 878376-80-8, which entered STN on Mar. 28, 2006.
Efange, Simon M. N., et al; Vesamicol Analogues as Sigma Ligands;Biochemical Pharmacology, vol. 49, No. 6 pp. 791-797, 1995.
Abdel-Magid, A., “Reductive Amination of Aldehydes and Ketones with Sodium Triacetoxyborohydride. Studies on Direct and Indirect Reductive Amination Procedures1”, J. Org. Chem., 61 (1996), pp. 3849-3862.
Bignan, G., “Preparation of 3-Spirocyclic Indolin-2-ones as Ligands for the ORL-1 Receptor”, Bioorganic and Medicinal Chem. Lett, 15 (2005), pp. 5022-5026.
Butera, J., “Recent Approaches to the Treatment of Urinary Incontinence: A Survey of Patent Activity from 1995 to 1998”, Expert Opinion on Therapeutic Patents, 8(8) (1998), pp. 1017-1035.
Bymaster, F., “Xanomeline: A Selective Muscarinic Agonist for the Treatment of Alzheimer's Disease”, Drug Development Research, 40 (1997), pp. 158-170.
Caufield, M.P., “International Union of Pharmacology. XVII. Classification of Muscarinic Acetylcholine Receptors”, Pharmacol. Rev., 50 (1998), pp. 279-290.
Caufield, M.P., “Muscarinic Receptors-Characterization, Coupling and function”, Pharmac. Ther., vol. 58 (1993), pp. 319-379.
Cheng, Y., “Solid Phase Synthesis of Spiroindoline”, Tet. Lett., 38 (1997), pp. 1497-1500.
Chiaverelli, S., “Ricerche nella serle della 4-feniipiperidina. Nota v. Derivati della 4,4′-spiro-(1″metilpiperidin)-1,2,3,4,-tetraidroisochinolina”, Gazzetta Chimica Italiana, 90, 189 (1960), CN1535967.
Custers, F., “Vesamicol and Some of its Derivatives: Questionable Ligands for Selectively Labelling Acetylcholine Transporters in Rat Brain”, Eur. Jour. of Pharm., 338 (1997), pp. 177-183.
deLaszlo, S., “A Nonpeptidic Agonist Ligand of the Human C5A Receptor: Synthesis, Binding Affinity Optimization and functional Characterization”, Bioorganic and Medicinal Chem. Lett., 7(2) (1997), pp. 213-218.
Dhar, T.G., “Design and Synthesis of Novel α1a Adrenoceptor-Selective Antagonists. 2. Approaches to Eliminate Opioid Agonist Metabolites via Modification of Linker and 4-Methoxycarbonyl-4-phenylpiperidine Moiety1.2”, J. Med. Chem, 42 (1999), pp. 4778-4793.
Efange, S., “(+)-p-([18F]Fluorobenzyl)Spirotrozamicol {(+)-[18F]Spiro-FBT}: Synthesis and
Davies Robert
Xu Jingwang
Coughlin Matthew
Forbes Christopher C.
Honigman Miller Schwartz and Cohn LLP
Kosack Joseph
O'Brien Jonathan P.
LandOfFree
Modulators of muscarinic receptors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Modulators of muscarinic receptors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modulators of muscarinic receptors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2623398